欧美亚洲国内精品bt,欧美激情精品久久久久久蜜臀,欧美a级免费黄片视频,久久一区二区三区精品

當(dāng)前位置:首頁(yè)  >  技術(shù)文章  >  EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤(rùn)相關(guān)

EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤(rùn)相關(guān)

更新時(shí)間:2024-12-28  |  點(diǎn)擊率:197

20231月,汕頭大學(xué)醫(yī)學(xué)院第二附屬醫(yī)院泌尿外科;廣州醫(yī)科大學(xué)第五附屬醫(yī)院泌尿外科;中山大學(xué)第一附屬醫(yī)院泌尿外科 (Department of Urology, The Second Affiliated Hospital of Shantou University, Medical College,Shantou 515041, ChinaDepartment of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, China;Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China) Hao Lin老師研究團(tuán)隊(duì)在《Cancers》上發(fā)表論文:

EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer"

 

EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤(rùn)相關(guān)"

 

Abstract

Purpose: To assess the mechanism of EPH receptor A3 (EPHA3) and its potential value for immunotherapy in BLCA.

Materials and methods: The Cancer Genome Atlas (TCGA) bladder cancer (BLCA) database and the Gene Expression Omnibus (GEO) database were used for assessing whether EHPA3 could be used to predict BLCA prognosis. This work carried out in vitro and in vivo assays for exploring how EPHA3 affected the biological behaviors. The downstream pathway was explored using a Western blotting technique. The CIBERSORT, ESTIMATE, TIMER, and TIDE tools were used to predict the immunotherapy value of EPHA3 in BLCA.

Results: EPHA3 was poorly expressed in BLCA (p < 0.05), its high expression is related to a good survival prognosis (p = 0.027 and p = 0.0275), and it has a good predictive ability for the histologic grade and status of BLCA (area under curve = 0.787 and 0.904). Overexpressed EPHA3 could inhibit BLCA cell biological behaviors, and it be associated with the downregulation of the Ras/pERK1/2 pathway. EPHA3 was correlated with several immune-infiltrating cells and the corresponding marker genes.

Conclusions: EPHA3 could be regarded as an acceptable anti-cancer biomarker in BLCA. EPHA3 plays an inhibiting role in BLCA, and it could be the candidate immunotherapeutic target for BLCA.


摘要:

目的:探討EPH受體A3 (EPHA3)的作用機(jī)制及其在BLCA免疫治療中的潛在價(jià)值。材料與方法:采用Cancer Genome Atlas (TCGA)膀胱癌(BLCA)數(shù)據(jù)庫(kù)和Gene Expression Omnibus (GEO)數(shù)據(jù)庫(kù)評(píng)估EHPA3是否可用于預(yù)測(cè)BLCA預(yù)后。本工作通過(guò)體外和體內(nèi)實(shí)驗(yàn)探討EPHA3對(duì)生物行為的影響。使用Western blotting技術(shù)探索下游途徑。采用CIBERSORT、ESTIMATETIMERTIDE工具預(yù)測(cè)EPHA3BLCA中的免疫治療價(jià)值。結(jié)果:EPHA3BLCA中表達(dá)較低(p < 0.05),其高表達(dá)與較好的生存預(yù)后相關(guān)(p = 0.027p = 0.0275),對(duì)BLCA的組織學(xué)分級(jí)和狀態(tài)有較好的預(yù)測(cè)能力(曲線下面積分別為0.7870.904)。EPHA3過(guò)表達(dá)可抑制BLCA細(xì)胞的生物學(xué)行為,并與Ras/pERK1/2通路下調(diào)有關(guān)。EPHA3與多種免疫浸潤(rùn)細(xì)胞及相應(yīng)的標(biāo)記基因相關(guān)。結(jié)論:EPHA3可作為BLCA的一種可接受的抗癌生物標(biāo)志物。EPHA3BLCA中具有抑制作用,可能成為BLCA的候選免疫治療靶點(diǎn)。

 

該論文中,人類膀胱癌細(xì)胞(5637、UMUC-3T24)以及正常的人類尿上皮細(xì)胞(SVHUC)的體外培養(yǎng)是使用Ausbian特級(jí)胎牛血清完成的。


国产一区精品在线| 日本不卡高清视频在线播放| A级毛片高清视频| 两个人免费视频高清| 免费看黑人操逼视频| 波多野吉衣一区在线观看| 骚货 淫水 国产| 亚洲日韩不卡一区二区三区| 亚洲av 又黄又爽十大| 开心五月播五月亚洲第一| 喜欢被粗大阴茎插入| 中文字幕国产精品一区二区三区| 欧美大鸡巴操大骚逼| 爱男爽高潮鸡穴视频| 欧美va精品亚洲va精品| 久久综合色鬼综合色| 亚洲天堂成年人在线视频| 翘臀小穴在线观看| 日本一区二区高清免费不卡| 亚洲一区亚洲二区在线观看| 国产精品视频美熟女一区二区| 国产裸体视频BBBBB| 亚洲欧美日韩另类| 男女操逼视频嫩嫩| 天天天天天干夜夜夜夜夜操| 日韩亚洲AV无码一区二区不卡| 午夜性刺激在线视频免费| 在线无码一区二区三区不卡| 黄色软件大屌怒戳粉嫩小穴| 99热这里有精品在线观看| 肏亚洲女人小骚逼| 九九在线视频热线视频精选| 黄片观看骚货浪荡| 男女插插调教骚逼| 挺进绝色邻居的紧窄小肉| 正在播放 国产精品推荐| 伊人久久综合无码成人网| 日韩高清精品一区有码在线| 国产精品午夜小视频观看| 国产一国产一级毛片无码视频百度| 日本精品久久人妻一区二区三区|